Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Monroe Capital Corporation Schedules Second Quarter 2025 Earnings Release
-
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
-
Tredegar Reports Second Quarter 2025 Results
-
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
-
Allison Transmission Declares Quarterly Dividend
-
WhiteFiber Announces Closing of Upsized Initial Public Offering
-
Cohen & Steers Announces Changes to Realty Indexes
-
DNP Select Income Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice
-
Coinbase to Participate in the Oppenheimer 28th Annual Technology, Internet & Communications Conference
-
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Commerce to Present at Upcoming Investor Conference
-
Supermicro Announces Participation in Upcoming Investor Events
-
Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025
-
Capital Clean Energy Carriers Corp. Announces Annual Meeting of Shareholders
-
Amwell makes grant to new employees under inducement plan
-
Femasys Announces Second Quarter Financial Results for 2025
-
Phunware Reports Second Quarter 2025 Financial Results
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
ClearSign Technologies Corporation Announces Realignment of Board of Directors to Support Next Phase of Growth
-
Heartland Physio Unveils The R.E.A.L. Recovery Experience for Singapore’s Active Professionals
-
NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
-
CSE Bulletin: Consolidation - Aether Global Innovations Corp. (AETH)
-
Stardust Solar Energy Inc. Announces Adoption of New By-Law No. 1 with Advance Notice Provisions
-
UPDATE – Currenc Group's Founder and Executive Chairman to Convert $54.6 Million in Loans to Equity
-
UPDATE – Currenc Group's Founder and Executive Chairman to Convert $54.6 Million in Loans to Equity
-
Exicure, Inc. Reports Second Quarter 2025 Financial Results
-
C1 Fund Inc. Announces Closing of Initial Public Offering
-
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025
-
Madison Liquidators Unveils "The Ultimate L-Shaped Desk Guide" -- The Definitive Resource for Workstation Inspiration and Office Planning
-
IPG Chicago Facility Achieves TRUE Gold Zero Waste Certification
-
Palatin Announces 1-for-50 Reverse Stock Split
-
RockBreaks – AI-Driven Energy Demands Highlight Strategic Value of Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Waterberg Project
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Brookfield Property Partners Declares Quarterly Dividends on Listed Preferred Units
-
Outdoor Holding Company Reports First Quarter Fiscal 2026 Financial Results
-
Simón Bolívar's Long-Lost Firearm Surfaces for Auction as Venezuela Captures Global Headlines
-
Walk Solutions Announces Banking Relationship with Old Glory Bank
-
Final Countdown: San Francisco Set to Host B2B’s Boldest Voices at Marketers Connect
-
Secret DUO Now Available at South Jersey Skin Care
-
AINewsBreaks – Spotlight on ONAR Holding Corp.’s (ONAR) Strategic Playbook: AI-Optimized Campaigns
-
IOTA Unveils Next-Gen Digital Asset Contract Platform, Enabling Global Users With Flexible Short-Term Participation
-
USX Cyber® Launches Integrated Application Control Module in GUARDIENT® Platform
-
First Horizon CFO Named to Super Women in Business Class of 2025
-
Saputo Announces Election of Directors
-
U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
-
U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
-
15 Days Until Pacific Pride Festival - Santa Barbara Gears Up for a Full Day of LGBTQ+ Joy, Art, and Entertainment
-
U-Haul Offers 30 Days Free Storage as Canyon Fire Forces Evacuations
